SL Science Holding Ltd (SLBT) shareholders
Close on Nov 17, 2026Market cap $356.14MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Ching-Dong Wang Joint filing with SL Link Holding Ltd. (58.72%) | 333,832,129 | 59.53% | 13D (active) amendment | Sep 29, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SLBT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 193,404 | – | $926.41K | New | 0.00% |
| L1 Global Manager Pty Ltd | 150,000 | – | $718.50K | New | 0.51% |
| Rivernorth Capital Management, LLC | 130,000 | – | $622.70K | New | 0.03% |
| Heights Capital Management, Inc | 20,000 | – | $95.80K | New | 0.02% |
| Lynx Capital Group Ltd /Adv | 17,096 | – | $81.89K | New | 0.03% |
| Jane Street Group, LLC | 14,540 | – | $69.65K | New | 0.00% |
| UBS Group AG | 12,515 | – | $59.95K | New | 0.00% |
| Osaic Holdings, Inc. | 286 | – | $1.37K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 8 | 1M | 8 / 0 | 0 / 0 | 1M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Chin-Sheng Hung | Chief Medical Officer, Director | – | Nov 6, 2026 |
| Ching-Dong Wang | Chief Executive Officer, Director, 10% owner | 333,832,129 | Oct 1, 2026 |
| Lok Sang Leung | Chief Financial Officer | – | Jun 16, 2026 |
| Qian Xu | Director | 20,000 | Jun 17, 2026 |
| John Conrad General | Director | – | Jun 16, 2026 |
| Mingche Liu | Director | – | Jun 16, 2026 |
| Kwo-Liang Chen | Director | – | Jun 16, 2026 |
| Joseph Levinson | Director | – | Jun 15, 2026 |
| Ethan Shen PhD | – | – | Nov 3, 2026 |
| Johnson Shun-Pong Lau | – | – | Sep 1, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ching-Dong Wang Chief Executive Officer, Director, 10% owner | Sep 29, 2026 | Buy | +4,545,306 | $2272653.00 | $10.33T | 333,832,129 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 5 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of SL Science's stock actually held short. Settlement fails (shares not delivered on time) peaked at 12,646 shares on Sep 28, 2026 over the last 90 days.
See a number that looks wrong?